Evidence map›Paper›PMID 27457803›Full record

ArticleBiochemical and biophysical research communications2016

Serum- and glucocorticoid-inducible kinases in microglia.

Koichi Inoue, Eisuke Sakuma, Hiroyuki Morimoto, Hayato Asai, Yoshinori Koide, Tiandong Leng, Ikuo Wada, Zhi-Gang Xiong, Takatoshi Ueki

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2019
    Article
  13. Review
  14. Review
  15. Potential implication of SGK1-dependent activity change in BV-2 microglial cells.International journal of physiology, pathophysiology and pharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Koichi InoueDepartment of Integrative Anatomy, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan; Neuroscience Institute, Morehouse School of Medicine, Atlanta, GA 30310, USA. Electronic address: ino-k@umin.ac.jp.
Eisuke SakumaDepartment of Integrative Anatomy, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Hiroyuki MorimotoDepartment of Rehabilitation Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Hayato AsaiDepartment of Integrative Anatomy, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Yoshinori KoideDepartment of Rehabilitation Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Tiandong LengNeuroscience Institute, Morehouse School of Medicine, Atlanta, GA 30310, USA.
Ikuo WadaDepartment of Rehabilitation Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Zhi-Gang XiongNeuroscience Institute, Morehouse School of Medicine, Atlanta, GA 30310, USA.
Takatoshi UekiDepartment of Integrative Anatomy, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Nagoya City University · JPMorehouse School of Medicine · US

Funding

Morehouse School of Medicine Center of Excellence Research Endowment ProgramS21MD000101 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI MONTGOMERY-RICE, VALERIE C. · 2001 to 2015
$74.3M
ASICs and increased ischemic brain injury in diabetic conditionR01NS066027 · NINDS · MOREHOUSE SCHOOL OF MEDICINE · PI XIONG, ZHIGANG · 2011 to 2015
$1.6M
NIMHD NIH HHS S21 MD000101NINDS NIH HHS R01 NS066027
6 · The paper itself

Abstract

Microglia are derived from myelogenous cells and contribute to immunological and inflammatory responses in central nervous system. They play important roles not only in infectious diseases and inflammation after stroke, but also in psychiatric diseases such as schizophrenia. While recent studies suggest the significances of serum- and glucocorticoid-inducible kinases (SGKs) in other immune cells such as macrophages, T cells and dendritic cells, their role in microglia remains unknown. Here we, for the first time, report that SGK1 and SGK3 are expressed in multiple microglial cell lines. An SGK inhibitor, gsk650394, inhibits cell viability. In addition, lipopolysaccharide-induced expression of inflammatory regulators iNOS and TNFα was enhanced by gsk650394. Furthermore, translocation of NF-κB was enhanced by gsk650394. Taken together, these findings suggest that SGKs may play an important role in regulating microglial viability and inflammatory responses.

Indexed as

AnimalsCell SurvivalCerebral CortexImmediate-Early ProteinsInflammationMaleMiceMice, Inbred C57BLMicrogliaNF-kappa BProtein Kinase InhibitorsProtein Serine-Threonine KinasesSerum-Glucocorticoid Regulated KinasesSignal TransductionImmediate-Early ProteinsNF-kappa BProtein Kinase InhibitorsProtein Serine-Threonine KinasesSerum-Glucocorticoid Regulated KinasesSgk3 protein, mouseInflammationiNOSMicrogliaNF-κBSGK1

Identifiers

PMID27457803
PMCPMC4996278
OpenAlexW2477640413

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.